Skip to main navigation Skip to search Skip to main content

Long-term variability in glycemic control is associated with white matter hyperintensities in APOE4 genotype carriers with type 2 diabetes

  • Abigail Livny
  • , Ramit Ravona-Springer
  • , Anthony Heymann
  • , Rachel Priess
  • , Tammar Kushnir
  • , Galia Tsarfaty
  • , Leeron Rabinov
  • , Reut Moran
  • , Hadass Hoffman
  • , Itzik Cooper
  • , Lior Greenbaum
  • , Jeremy Silverman
  • , Mary Sano
  • , Sterling C. Johnson
  • , Barbara B. Bendlin
  • , Michal Schnaider Beeri

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

OBJECTIVE We assessed whether the apolipoprotein ϵ4 (APOE4) genotype affects the relationship of variability in long-term glycemic control (measured by HbA1c SD of multiple measurements) with white matter hyperintensities (WMHs) in elderly patients with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS WMH volume was generated from structural T1 and fluid-attenuated inversion recovery MRI in each subject. The analysis included 124 subjects; 27 (21.8%) had one or more APOE4 alleles. RESULTS HbA1c variability was associated with significantly higher WMH in APOE4 carriers (r 5 0.47, P 5 0.03), controlling for age, sex, mean HbA1c , number of follow-up years, and a composite of cardiovascular risk factors, but not in noncarriers (r 5 20.04, P 5 0.71; P for interaction 5 0.050). CONCLUSIONS The results suggest that the APOE4 genotype affects the relationship of long-term glycemic control with WMH load so that APOE4 carriers may be more vulnerable to the insults of poor control.

Original languageEnglish
Pages (from-to)1056-1059
Number of pages4
JournalDiabetes Care
Volume39
Issue number6
DOIs
StatePublished - 1 Jun 2016

Fingerprint

Dive into the research topics of 'Long-term variability in glycemic control is associated with white matter hyperintensities in APOE4 genotype carriers with type 2 diabetes'. Together they form a unique fingerprint.

Cite this